International Stem Cell Corporation (OTC:ISCO) has announced that its creation of human, cornea-like tissue in a petri dish was discussed in an article in Discovery News.  The article was named “Biotech Could Take Rabbits Off Lab Duty” and printed on the December 11, 2009 edition of Discovery News.  Reporter Alyssa Danigelis discussed the International Stem Cell researchers’ findings while studying growing stem cells in the lab using blastocysts in the article, taking note of ISCO’s previous announcement on the subject.

Simply Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.

Sign Up for our Free Stock Newsletter

A biotechnology company, International Stem Cell Corporation is focused on the development of therapeutic and research products.  It’s objective is to create an unlimited source of human cells to use in the treatment of diseases including diabetes, liver disease, corneal disease, and retinal disease through cell transplant therapy.

Sign up for the free Simply Best Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

Follow Simply Best Penny Stocks on Twitter: http://www.Twitter.com/simplybestps

About Us

Simply Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

Please click here to read the full disclaimer.